Literature DB >> 1777415

Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma.

E C Douglass1, S T Rowe, M Valentine, D M Parham, R Berkow, W P Bowman, H M Maurer.   

Abstract

In three cases of alveolar rhabdomyosarcoma with variant translocations, two tumors contained an identical translocation, t(1;13)(p36.1;q14); the third tumor contained a t(8;13)(p21;q14). All three patients were 2 years old, markedly younger than the median age for patients with t(2;13)-positive alveolar rhabdomyosarcoma. The alteration of genetic material on chromosome 13 may be of primary importance in the development of alveolar rhabdomyosarcoma.

Entities:  

Mesh:

Year:  1991        PMID: 1777415     DOI: 10.1002/gcc.2870030611

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  13 in total

1.  A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.

Authors:  S Gattenloehner; B Dockhorn-Dworniczak; I Leuschner; A Vincent; H K Müller-Hermelink; A Marx
Journal:  J Mol Diagn       Date:  1999-11       Impact factor: 5.568

2.  Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement.

Authors:  L Krsková; M Mrhalová; D Sumerauer; R Kodet
Journal:  Virchows Arch       Date:  2005-12-20       Impact factor: 4.064

3.  Amplification of the t(2; 13) and t(1; 13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction.

Authors:  J Anderson; J Renshaw; A McManus; R Carter; C Mitchell; S Adams; K Pritchard-Jones
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

4.  The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors.

Authors:  S Gattenloehner; A Vincent; I Leuschner; S Tzartos; H K Müller-Hermelink; T Kirchner; A Marx
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  Cytogenetic study of botryoid rhabdomyosarcoma of the uterine cervix.

Authors:  J P Palazzo; Z Gibas; C J Dunton; A Talerman
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 6.  Clinical aspects of alveolar rhabdomyosarcoma with translocation t(1;13)(p36;q14) and hypotetraploidy.

Authors:  B Gunawan; L Füzesi; B Granzen; U Keller; R Mertens; G Steinau; V Schumpelick
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

7.  PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma.

Authors:  J Anderson; A Ramsay; S Gould; K Pritchard-Jones
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 8.  Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.

Authors:  N J Sebire; M Malone
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

Review 9.  The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker.

Authors:  Abby R Rosenberg; Stephen X Skapek; Douglas S Hawkins
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-07       Impact factor: 4.254

10.  Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma.

Authors:  J R Downing; A Khandekar; S A Shurtleff; D R Head; D M Parham; B L Webber; A S Pappo; M G Hulshof; W P Conn; D N Shapiro
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.